key: cord-0909845-keq8h9pg
authors: Patel, Rutwik; Chowdhury, Sudipa; Meng, William; Sharma, Hari; Bellary, Sharath; Mishra, Sumitanand; Miller, Richard
title: AN ISOLATED PLEURAL EFFUSION AS A SEQUELA OF COVID-19 INFECTION
date: 2020-10-31
journal: Chest
DOI: 10.1016/j.chest.2020.08.362
sha: 41789a4d3d0be26b6efabf37b6a27dff9eb4e665
doc_id: 909845
cord_uid: keq8h9pg

nan

INTRODUCTION: Since December 2019, the coronavirus disease 2019 (COVID-19) outbreak has resulted in widespread transmission and death. Understanding how this viral pneumonia causes acute lung injury is evolving, but it typically manifests as peripheral bilateral ground glass on chest imaging. We report a unique case of a COVID-19 patient who presented with a new isolated left pleural effusion that is likely a sequela of the infection.

A 25-year-old female with no co-morbidities was seen in ED at another hospital for flu-like symptoms and found to have COVID-19. At that time, her chest radiograph showed hazy opacities overlying left greater than right lung lobes consistent with multifocal pneumonia. She was discharged home on doxycycline. Patient felt better following discharge but then presented to our hospital four weeks later with left sided pleuritic chest pain of two weeks duration. She denied any fever, cough, recent travel, or sick contacts. Vital signs were: T 99.4 F, HR 97, BP 109/76, RR 20, and 96 % O2 saturation on room air. Physical exam was significant for decreased air entry at left lung base. A comprehensive metabolic panel, complete blood count, troponins, BNP, and LDH were within normal limits. However, D-dimer was elevated. Both chest radiograph and CT chest angiogram showed a new moderate left pleural effusion, but in addition CT showed ground glass opacities in the left upper and right lower lung lobes noted on the CT. Patient was started on empiric antibiotics. Her symptoms improved after 700 cc of serous pleural fluid was drained via a pigtail catheter. Pleural fluid analysis showed an overtly exudative fluid with protein ratio of 0.74 and LDH ratio of 3.08 with fluid LDH of 719. Other pertinent fluid analysis revealed: pH 7.5, WBC 9744 with 60% neutrophils, with no organisms on gram stain or culture. Fluid cytology showed numerous acute and chronic inflammatory cells and few macrophages admixed with degenerated cells. Patient underwent repeat COVID-19 testing via the nasal swab and pleural fluid PCR, which were both negative.

DISCUSSION: Pleural effusions can be related to diseases of the lungs and heart or to a systemic disease. To treat pleural effusions, it is important to determine the etiology. In this case, given the patient's history of COVID-19 infection and exclusion of all other causes, the exudative predominantly neutrophilic pleural effusion most likely reflected a parapneumonic effusion.

CONCLUSIONS: COVID-19 can present with non-specific imaging findings; however, to our knowledge, an isolated pleural effusion has not been reported in patients with COVID-19.

Coronavirus disease 2019 (COVID-19): Clinical features and diagnosis

COVID-19 pneumonia: A review of typical CT findings and differential diagnosis

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection